Cargando…

Biomarker of Neuroinflammation in Parkinson’s Disease

Parkinson’s disease (PD) is caused by abnormal accumulation of α-synuclein in dopaminergic neurons of the substantia nigra, which subsequently causes motor symptoms. Neuroinflammation plays a vital role in the pathogenesis of neurodegeneration in PD. This neuroinflammatory neurodegeneration involves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Tsai-Wei, Chen, Chiung-Mei, Chang, Kuo-Hsuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028544/ https://www.ncbi.nlm.nih.gov/pubmed/35456966 http://dx.doi.org/10.3390/ijms23084148

Ejemplares similares

The Role of Oxidative Stress in Parkinson’s Disease
por: Chang, Kuo-Hsuan, et al.
Publicado: (2020)

Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson’s Disease Targeting Neuroinflammation
por: Chen, Chiung-Mei, et al.
Publicado: (2021)

Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease
por: Chang, Kuo-Hsuan, et al.
Publicado: (2022)

Microglia and Astrocytes Dysfunction and Key Neuroinflammation-Based Biomarkers in Parkinson’s Disease
por: Chen, Kun, et al.
Publicado: (2023)

Glycosphingolipids and neuroinflammation in Parkinson’s disease
por: Belarbi, Karim, et al.
Publicado: (2020)

Lactulose and Melibiose Attenuate MPTP-Induced Parkinson’s Disease in Mice by Inhibition of Oxidative Stress, Reduction of Neuroinflammation and Up-Regulation of Autophagy
por: Lin, Chih-Hsin, et al.
Publicado: (2020)

Epigenetic Regulation of Neuroinflammation in Parkinson’s Disease
por: Rasheed, Madiha, et al.
Publicado: (2021)

Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson’s Disease: Roads to Biomarker Discovery
por: Picca, Anna, et al.
Publicado: (2021)

The Contribution of Microglia to Neuroinflammation in Parkinson’s Disease
por: Badanjak, Katja, et al.
Publicado: (2021)

Microglia Mediated Neuroinflammation in Parkinson’s Disease
por: Isik, Sevim, et al.
Publicado: (2023)

Alterations of Plasma Galectin-3 and C3 Levels in Patients with Parkinson’s Disease
por: Wu, Hsiu-Chuan, et al.
Publicado: (2021)

Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies
por: Rocha, Natália Pessoa, et al.
Publicado: (2015)

Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease
por: Gelders, Géraldine, et al.
Publicado: (2018)

Neuroinflammation in Parkinson’s disease and its potential as therapeutic target
por: Wang, Qinqin, et al.
Publicado: (2015)

Neuroinflammation and Autophagy in Parkinson’s Disease—Novel Perspectives
por: Minchev, Danail, et al.
Publicado: (2022)

The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease
por: Jurcau, Anamaria, et al.
Publicado: (2023)

Association between CSF1 and CSF1R Polymorphisms and Parkinson’s Disease in Taiwan
por: Chang, Kuo-Hsuan, et al.
Publicado: (2019)

Neuroinflammation in Parkinson’s Disease and its Treatment Opportunities
por: Çınar, Elif, et al.
Publicado: (2022)

The Involvement of Neuroinflammation and Kynurenine Pathway in Parkinson's Disease
por: Zinger, Anna, et al.
Publicado: (2011)

The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease
por: Tufekci, Kemal Ugur, et al.
Publicado: (2011)

Upregulation of APAF1 and CSF1R in Peripheral Blood Mononuclear Cells of Parkinson’s Disease
por: Chang, Kuo-Hsuan, et al.
Publicado: (2023)

The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
por: Heidari, Arash, et al.
Publicado: (2022)

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities
por: Araújo, Bruna, et al.
Publicado: (2022)

LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
por: Russo, Isabella, et al.
Publicado: (2014)

Association between GRN rs5848 Polymorphism and Parkinson′s Disease in Taiwanese Population
por: Chang, Kuo-Hsuan, et al.
Publicado: (2013)

Polymorphisms of ACMSD-TMEM163, MCCC1, and BCKDK-STX1B Are Not Associated with Parkinson's Disease in Taiwan
por: Chang, Kuo-Hsuan, et al.
Publicado: (2019)

Transient receptor potential V1 modulates neuroinflammation in Parkinson’s disease dementia: Molecular implications for electroacupuncture and rivastigmine
por: Tsai, Sheng-Ta, et al.
Publicado: (2021)

Alternations of Lipoprotein Profiles in the Plasma as Biomarkers of Huntington’s Disease
por: Chang, Kuo-Hsuan, et al.
Publicado: (2023)

Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson's Disease
por: More, Sandeep Vasant, et al.
Publicado: (2013)

Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies
por: Terkelsen, Miriam Højholt, et al.
Publicado: (2022)

Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson’s Disease
por: Al-Nusaif, Murad, et al.
Publicado: (2022)

Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson’s Disease
por: Vallée, Alexandre, et al.
Publicado: (2020)

Neuroinflammation and Mitochondrial Dysfunction in Parkinson’s Disease: Connecting Neuroimaging with Pathophysiology
por: Pizarro-Galleguillos, Benjamin Matís, et al.
Publicado: (2023)

Phosphorylated α-synuclein in diluted human serum as a biomarker for Parkinson's disease
por: Chen, Wei-Ru, et al.
Publicado: (2022)

Cyclooxygenase and Neuroinflammation in Parkinson’s Disease Neurodegeneration
por: Bartels, Anna L, et al.
Publicado: (2010)

Genetic Polymorphisms Associated with Spontaneous Intracerebral Hemorrhage
por: Chen, Yi-Chun, et al.
Publicado: (2018)

Locus Coeruleus Modulates Neuroinflammation in Parkinsonism and Dementia
por: Giorgi, Filippo Sean, et al.
Publicado: (2020)

Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease
por: Ko, Chih-Jan, et al.
Publicado: (2021)

Oxidative Stress and Neuroinflammation in Parkinson’s Disease: The Role of Dopamine Oxidation Products
por: Chakrabarti, Sasanka, et al.
Publicado: (2023)

Neuroinflammation in Parkinson’s Disease: From Gene to Clinic: A Systematic Review
por: Castillo-Rangel, Carlos, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i9jedgn8tbqffebu52jmjfnua5